Human Microbiome Sequencing Technology Market

Human Microbiome Sequencing Technology Market contains market size and forecasts of Human Microbiome Sequencing Technology in Global, including the following market information:

Global Human Microbiome Sequencing Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Human Microbiome Sequencing Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Traditional Sequencing Technologies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Microbiome Sequencing Technology include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., Novogene Corporation and OraSure Technologies, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Human Microbiome Sequencing Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Microbiome Sequencing Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Human Microbiome Sequencing Technology Market Segment Percentages, by Type, 2021 (%)

Traditional Sequencing Technologies

Next-Generation Sequencing

Third Generation Sequencing

Global Human Microbiome Sequencing Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Human Microbiome Sequencing Technology Market Segment Percentages, by Application, 2021 (%)

Research and Academic Institutions

Pharmaceutical and Biotechnology Companies

Hospital and Clinic

Others

Global Human Microbiome Sequencing Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Human Microbiome Sequencing Technology Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Microbiome Sequencing Technology revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Human Microbiome Sequencing Technology revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Baseclear B.V.

Beijing Genomics Institute (BGI) Genomics Co., Ltd

Charles River Laboratories International Inc.

Clinical Microbiomics A/S

Eurofins Scientific SE

GENEWIZ, Inc.

Illumina, Inc.

Novogene Corporation

OraSure Technologies, Inc.

Oxford Nanopore Technologies, Inc.

Pacific Biosciences of California, Inc.

QIAGEN N.V.

Second Genome, Inc.

Thermo Fisher Scientific Inc.

Viome, Inc.

CosmosID

Leucine Rich Bio Pvt. Ltd.

Microba

Microbiome Insights Inc.

Molzym GmbH & Co. KG